Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Kuokkanen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 26, 2011
Current trends in the pharmaceutical industry--a case study approachAlexandru Rusu, Katja Kuokkanen, Annabelle Heier
Frontiers in Allergy|April 7, 2022
Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma?Rebecca J Thompson, Ian Sayers, Katja Kuokkanen, et al.
Neuropharmacology|December 17, 2009
Roles of cutaneous versus spinal TRPA1 channels in mechanical hypersensitivity in the diabetic or mustard oil-treated non-diabetic ratHong Wei, Hugh Chapman, Marja Saarnilehto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 24, 2002
Point: myeloperoxidase -463G --> a polymorphism and lung cancer riskAnne Feyler, Anu Voho, Christine Bouchardy, et al.
European Journal of Pharmacology|October 22, 2008
In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of actionJyrki Lehtimäki, Tiina Leino, Ari Koivisto, et al.
Pain|January 8, 2011
Spinal transient receptor potential ankyrin 1 channel contributes to central pain hypersensitivity in various pathophysiological conditions in the ratHong Wei, Ari Koivisto, Marja Saarnilehto, et al.
EJNMMI Research|December 9, 2020
Application of the PET ligand [<sup>11</sup>C]ORM-13070 to examine receptor occupancy by the α<sub>2C</sub>-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brainMohammed Shahid, Juha O Rinne, Mika Scheinin, et al.
Pharmacological Research|December 3, 2011
Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathyAri Koivisto, Mika Hukkanen, Marja Saarnilehto, et al.
Purinergic Signalling|May 25, 2024
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonistJessica Nagel, Olli Törmäkangas, Katja Kuokkanen, et al.
Basic & Clinical Pharmacology & Toxicology|May 31, 2013
Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric modelsJukka Sallinen, Johanna Holappa, Ari Koivisto, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 26, 2011
Current trends in the pharmaceutical industry--a case study approachAlexandru Rusu, Katja Kuokkanen, Annabelle Heier
Frontiers in Allergy|April 7, 2022
Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma?Rebecca J Thompson, Ian Sayers, Katja Kuokkanen, et al.
Neuropharmacology|December 17, 2009
Roles of cutaneous versus spinal TRPA1 channels in mechanical hypersensitivity in the diabetic or mustard oil-treated non-diabetic ratHong Wei, Hugh Chapman, Marja Saarnilehto, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 24, 2002
Point: myeloperoxidase -463G --> a polymorphism and lung cancer riskAnne Feyler, Anu Voho, Christine Bouchardy, et al.
European Journal of Pharmacology|October 22, 2008
In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of actionJyrki Lehtimäki, Tiina Leino, Ari Koivisto, et al.
Pain|January 8, 2011
Spinal transient receptor potential ankyrin 1 channel contributes to central pain hypersensitivity in various pathophysiological conditions in the ratHong Wei, Ari Koivisto, Marja Saarnilehto, et al.
EJNMMI Research|December 9, 2020
Application of the PET ligand [<sup>11</sup>C]ORM-13070 to examine receptor occupancy by the α<sub>2C</sub>-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brainMohammed Shahid, Juha O Rinne, Mika Scheinin, et al.
Pharmacological Research|December 3, 2011
Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathyAri Koivisto, Mika Hukkanen, Marja Saarnilehto, et al.
Purinergic Signalling|May 25, 2024
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonistJessica Nagel, Olli Törmäkangas, Katja Kuokkanen, et al.
Basic & Clinical Pharmacology & Toxicology|May 31, 2013
Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric modelsJukka Sallinen, Johanna Holappa, Ari Koivisto, et al.
Pageof 2